Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes.
Saved in:
| Title: | Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes. |
|---|---|
| Authors: | Lim CE; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden., Pasternak B; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden.; Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark., Eliasson B; Department of Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden.; The Swedish National Diabetes Register, Center of Registers, Medicinaregatan 18 G, 413 45 Gothenburg, Sweden., Danaei G; Department of Global Health and Population, Harvard TH Chan School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA., Ueda P; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden. |
| Source: | European journal of preventive cardiology [Eur J Prev Cardiol] 2023 Jun 01; Vol. 30 (8), pp. 634-643. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2047-4881 |
|---|---|
| DOI: | 10.1093/eurjpc/zwac315 |
